Mavis et al. showed that promoter DNA hypermethylation appeared to inhibit GSTK1 gene expression in the normal murine prostate, and that GSTK1 genes are extensively downregulated in primary transgenic prostate adenocarcinoma (Mavis et al., 2009). This evidence concerns the gene GSTK1 and prostate adenocarcinoma.